Anúncio
Anúncio

PRPH

PRPH logo

ProPhase Labs, Inc. Common Stock (DE)

0.45
USD
Patrocinado
0.00
-0.89%
30 de dez., 15:52 UTC -5
Encerrado
exchange

Pré-Mercado

0.45

0.00
-0.95%

Relatórios de Lucros PRPH

Rácio de surpresa positiva

PRPH separação 8 de 19 últimas estimativas.

42%

Próximo Relatório

Data do Próximo Relatório
30 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$9.86M
/
-$0.12
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
-497.08%
/
-99.25%

ProPhase Labs, Inc. Common Stock (DE) earnings per share and revenue

On 17 de nov. de 2025, PRPH reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.11 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 5.80 milhão, with a --% difference.
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.12 USD, with revenue projected to reach 9.86 milhão USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, ProPhase Labs, Inc. Common Stock (DE) reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 30 de mar. de 2026.
Based on 3 analistas, ProPhase Labs, Inc. Common Stock (DE) is expected to report EPS of -$0.12 and revenue of $9.86M for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio